Prevention of Hemorrhage After Implantation of Mechanical Circulatory Support
Status:
Terminated
Trial end date:
2018-09-05
Target enrollment:
Participant gender:
Summary
Main objective of the study is to demonstrate that a prophylactic treatment with VWF factor
concentrate after implantation of continuous-flow left ventricular assist device (CF-LVAD)
reduces the frequency of clinically significant bleeding within 3 months after implantation
in comparison to the usual care. Adult patients with functional defects of VWF measured after
implantation of continuous LVAD are randomly assigned to prophylactic treatment.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Lille
Collaborators:
Laboratoire français de Fractionnement et de Biotechnologies Ministry of Health, France